Efficacy of Lamivudine in Patients with Hematologic Malignancies Receiving Chemotherapy and Precore Mutant Chronic Active Hepatitis B

Publisher： Karger

E-ISSN： 1421-9662|107|1|49-51

ISSN： 0001-5792

Source： Acta Haematologica, Vol.107, Iss.1, 2002-01, pp. : 49-51

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Optimization of lamivudine therapy

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 4, 2015-04 ,pp. : 748-755

John Wiley & Sons Inc

Access to resources Recommend Favorite

Continued Lamivudine Therapy in Patients with Chronic Hepatitis B

By  

Intervirology, Vol. 46, Iss. 6, 2003-12 ,pp. : 377-387

Karger

Access to resources Recommend Favorite

Eighteen‐month lamivudine prophylaxis on preventing occult hepatitis B virus infection reactivation in patients with haematological malignancies receiving immunosuppression therapy

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 25, Iss. 2, 2018-02 ,pp. : 198-204

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prevention of acute exacerbation of chronic hepatitis B infection in cancer patients receiving chemotherapy in a hepatitis B virus endemic area

By  

HEPATOLOGY, Vol. 62, Iss. 2, 2015-08 ,pp. : 387-396

John Wiley & Sons Inc

Access to resources Recommend Favorite

Response to Adefovir Depends on Mutation Patterns in Precore Region, Basal Core Promoter and Reverse Transcriptase, and On-Treatment Responses in Lamivudine-Resistant Chronic Hepatitis B Patients

By  

Intervirology, Vol. 53, Iss. 4, 2010-03 ,pp. : 203-210

Karger

Access to resources Recommend Favorite